Explore the Global SPECT/PET Radiopharmaceutical Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

SPECT/PET Radiopharmaceutical Market

Key Insight

FMI is of the opinion that supplier preference will be shaped by isotope availability discipline and site-level compliance readiness, as imaging networks tighten scheduling reliability and chain-of-custody expectations for time-sensitive products.

February 26, 2026

Anurag Sharma

250 Pages

Cite this Report

SPECT/PET Radiopharmaceutical Market

https://www.futuremarketinsights.com/reports/spect-pet-radiopharmaceutical-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Bayer
Boston Scientific
Cardinal Health
Curium Pharma
Eli Lilly and Company
GE HealthCare Technologies Inc
Jubilant DraxImage Inc
Lantheus Holdings
Life Molecular Imaging GmbH
NorthStar Medical Radioisotopes
Novartis
Q BioMed Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

SPECT/PET Radiopharmaceutical Market

Key Players

Similar Industry Reports